The Research Behind the Work
For those considering a psilocybin journey, the studies below underscore the medicine's efficacy, safety, and profound impact when administered in a professional, supported setting.
Longevity
Psilocybin treatment extends cellular lifespan and promotes increased longevity in aged mice, suggesting that psilocybin may be a potent geroprotective agent.
Psilocybin Treatment Extends Cellular Lifespan and Improves Survival of Aged Mice
Psilocybin can extend human cell lifespan by over 50% and boost survival rates by 30% in older mice, hinting at potential anti-aging benefits beyond its psychological effects.
Depression Treatment
Multiple studies, including randomized clinical trials and meta-analyses, suggest that one or two doses of psilocybin in a therapeutic relationship can result in rapid, significant, and sustained reductions in depressive symptoms, with effects lasting up to a year for most patients.
Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients
Two doses of psilocybin with therapy led to lasting relief from depression symptoms.
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial
Reductions in depressive symptoms with psilocybin therapy, highlighting its potential as an adjunct to psychotherapy.
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial
Quick onset and durability of a single psilocybin dose in treating major depression.
Psilocybin-Assisted Therapy for Depression: A Systematic Review and Meta-Analysis
Meta-analysis confirming large antidepressant effects from psilocybin therapy.
Efficacy of Psilocybin for Treating Symptoms of Depression: Systematic Review and Meta-Analysis
BMJ meta-analysis supporting psilocybin's superiority over placebo for depression.
Addiction Therapy
Pilot studies show psilocybin-assisted therapy, paired with cognitive behavioral or motivational therapy, aids smoking cessation and reduces alcohol dependence, with sustained abstinence observed at 12 months.
Psilocybin Facilitates Smoking Cessation: A Pilot Study
Psilocybin with cognitive behavioral therapy helps long-term smokers quit, with sustained abstinence at 12 months.
Psilocybin-Assisted Treatment for Alcohol Dependence: A Proof-of-Concept Study
Psilocybin's potential with motivational therapy to reduce alcohol dependence.
Broader Therapeutic Potential
Psilocybin shows promise for anxiety and other mental health conditions, with mystical-type experiences contributing to long-term well-being.
Clinical Potential of Psilocybin as a Treatment for Mental Health Conditions
A review outlining psilocybin's promise for depression, anxiety, and addictions.
Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review
Overview of psilocybin's role in treating mental illnesses like depression and addiction.
Potential Therapeutic Effects of Psilocybin: A Systematic Review
Affirms psilocybin's positive benefit-risk profile for treatment-resistant conditions.
Psilocybin Can Occasion Mystical-Type Experiences Having Substantial and Sustained Personal Meaning and Spiritual Significance
Foundational trial showing psilocybin induces profound, meaningful experiences with sustained well-being benefits.
Neurological Effects
Neuroimaging studies reveal psilocybin desynchronizes brain networks, particularly the default mode network, leading to increased global integration and altered perception, which correlate with therapeutic benefits.
Increased Global Integration in the Brain After Psilocybin Therapy for Depression
Brain changes post-psilocybin that correlate with antidepressant effects.
Psilocybin Desynchronizes the Human Brain
How psilocybin alters brain networks for lasting therapeutic effects.
Neural Correlates of the Psychedelic State via fMRI with Psilocybin
Psilocybin's reduction of default mode network activity explaining its effects on perception and consciousness.
Disclaimer: The scientific literature presented here is for educational purposes. Sangam provides a professional framework for supported psilocybin journeys but does not provide medical or psychiatric treatment for clinical conditions. Always consult with a qualified health professional regarding your individual health needs.